Preferred Label : angiotensin-converting enzyme inhibitor agent, nos;

Details


Main resources

You can consult :


https://www.cochrane.org/fr/CD006257/RENAL_inhibiteurs-de-lenzyme-de-conversion-de-langiotensine-et-antagonistes-des-recepteurs-de
2024
United Kingdom
review of literature
french abstract
Progression
Upon Progression
diabetic nephropathies
angiotensin receptor site
Diabetic Nephropathy
angiotensin-converting enzyme inhibitor agent, nos
Receptor
Preventive Intervention
ACE Inhibitor
Prevention
angiotensin-converting enzyme inhibitors
angiotensin receptor antagonists
Prevention Study
Cancer Progression

---
https://n2t.net/ark:/47881/m64x57rx
2023
France
dissertations, academic
arteriopathy
Meta-Analysis
randomized controlled trials as topic
Efficacy Study
occlusion of artery, nos
Arterial Disorder
efficiency
meta-analysis as topic
all extremities
arterial occlusive diseases
extremities
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitor agent, nos
Murine Limb
Review
Meta-Analysis
classification
Systematic Review
ACE Inhibitor
Extremity Part
Membership

---
http://www.sudoc.fr/203627458
2017
false
false
false
France
French
dissertations, academic
therapeutics
angiotensin II receptor antagonists
efficiency
achievement
effective
angiotensin receptor antagonists
hypotensive agent, nos
angiotensin-converting enzyme inhibitor agent, nos
operations research
antihypertensive agents
angiotensin-converting enzyme inhibitors
Meta-Analysis
angiotensin ii receptor antagonist, nos
Treatment Efficacy
meta-analysis as topic
clinical
meta-analysis
treatment outcome

---
Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.